Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dgxJCduTtWCbdCwwCidawyCicNomPr
   | Health Care & Policy |  |  | | - Experts link gene variant to poor response to asthma inhalers
U.S. scientists reported in the New England Journal of Medicine that asthma patients who inherited two copies of a mutation in the GLCCI1 gene have lower chances of responding to steroid inhalers than those with two regular copies of the gene. "The study illustrates the importance of research examining the relationship between genetic makeup and response to therapy for asthma, and underscores the need for personalized treatment for those who have it," said Dr. Susan Shurin, interim director of the National Heart Lung and Blood Institute. Reuters (9/26)        | Fly a lot? Earn 3X rewards points on airline purchases with The New Business Gold Rewards Card from American Express OPEN. Designed to earn Membership Rewards® points faster:
• 3X points on airfare
• 2X points on advertising, gas, and shipping
• 1X points on everything else
• Plus, 50K bonus points when you spend $10K your first 5 months
LEARN MORE AND APPLY |
  - Funding round brings in $17 million for Elevation Pharmaceuticals
Elevation Pharmaceuticals raised $17 million in a round of Series A financing. The San Diego firm will use the proceeds to support a Phase II clinical trial of EP-101, a drug candidate for chronic obstructive pulmonary disease. Elevation also announced the appointment of Pravin Soni as chief technical officer and Jaisim Shah as chief business officer. Xconomy/San Diego (9/26) - Agile Sciences secures NIH grant for anti-biofilm compounds
The NIH has awarded a phase 1 Small Business Innovation Research Grant worth $545,000 to Agile Sciences to help the startup further develop its compounds derived from sea sponges designed to disperse biofilms. Agile CEO Keith Stoneback said the company would use the grant to employ additional workers. MedCityNews.com (9/26)  | LET’S GO DESIGN: Episode #4
In this episode of SolidWorks’ interactive web series, host Jeremy Luchini starts designing the chassis of the Hot Rod Baby Buggy using weldment features and sketch techniques. He also visits a metal fabrication shop to learn about methods that will help in building our project. Watch the new episode now at LetsGoDesign.tv |
 | Global Developments | | | | - Kowa gives up 50% stake in generics venture with Teva
Teva Pharmaceutical Industries paid $150 million to acquire Kowa's 50% stake in their Japanese generic-drug venture, Teva-Kowa Pharma. The purchase allows Teva to operate independently, said President and CEO Shlomo Yanai. Teva has "a target of reaching $1 billion in sales in Japan by 2015, but we will be there before 2015," Yanai said. Reuters (9/26) - Mesoblast signs manufacturing deal with Lonza
Mesoblast signed a deal with Lonza Group to produce the former's regenerative therapies on a large scale. The deal allows Mesoblast to call on Lonza to set up a manufacturing facility specifically for its products. Mesoblast has experimental therapies for heart failure and spinal injuries in late-stage trials. Bloomberg (9/26)  | |  | | The Buzz(CORPORATE ANNOUNCEMENTS)
| |  | |  |
| Industrial & Environmental | | | | | News from BIO | | | | - BIOtechNOW
BIOtechNOW is the first in a number of new products from BIO intended to enhance our communications with the biotech community -- not only with our members, but with other stakeholders as well. This monthly e-newsletter, combined with its website, serves as our flagship in that effort. BIOtechNOW will offer original content that emphasizes the business needs of the industry; highlight BIO's advocacy efforts; and provide a portal to all BIO activities and events. Most importantly, it will spotlight for those outside the industry the value of biotechnology. Sign up for the monthly BIOtechNOW e-newsletter.
| SmartQuote | | | |  | Failure is not fatal, but failure to change might be."
--John Wooden,
American basketball player and coach  |
| | This SmartBrief was created for jmabs1@gmail.com
| | | Read more at SmartBrief.com | | A powerful website for SmartBrief readers including: | | | | | | | | | | Recent BIO SmartBrief Issues: - Monday, September 26, 2011
- Friday, September 23, 2011
- Thursday, September 22, 2011
- Wednesday, September 21, 2011
- Tuesday, September 20, 2011
| | | Lead Editor: Adam Gaub
Mailing Address:
SmartBrief, Inc.®, 1100 H ST NW, Suite 1000, Washington, DC 20005 | | | | | | © 1999-2011 SmartBrief, Inc.® Legal Information |
|
No comments:
Post a Comment